Literature DB >> 2413382

Dopamine and serotonin metabolism in striatum and in the septohippocampal pathway of the Snell dwarf mouse.

E Kempf, G Fuhrmann, G Thiriet, A Ebel.   

Abstract

Dopamine and serotonin neurotransmission has been investigated in striatum and in the septohippocampal pathway of the locomotor activity and memory deficient Snell dwarf mouse. In striatum a sharp decrease in 3-MT levels with a concomitant decrease in DA turnover is indicative of a strong decrement in the functional activity of striatal dopaminergic terminals in the mutant mouse. The observed enhancement in serotoninergic markers (5HT, 5HIAA, 5 HTP), at the opposite, provide evidence for an altered relationship between serotonin and dopamine striatal neurotransmission in the mutant mouse as compared to the normal mouse. Impairment in dopamine and serotonin neurotransmission has also been observed in the septohippocampal pathway where the removal of acidic metabolites of these neurotransmitters from brain appears to be disturbed. The data presented here are discussed with regard to previously noted alterations in cholinergic activity as well as to the behavioral disturbances of the dwarf mutant.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2413382     DOI: 10.1007/bf00964633

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  30 in total

Review 1.  Brain biogenic amines and altered thyroid function.

Authors:  R L Singhal; R B Rastogi; P D Hrdina
Journal:  Life Sci       Date:  1975-12-01       Impact factor: 5.037

2.  Effects of hippocampal electrical stimulation on longterm memory and on cholinergic mechanisms in three inbred strains of mice.

Authors:  R Jaffard; A Ebel; C Destrade; T Durkin; P Mandel; B Cardo
Journal:  Brain Res       Date:  1977-09-16       Impact factor: 3.252

3.  Cholinergic neurotransmission in the central nervous system of the Snell dwarf mouse.

Authors:  G Fuhrmann; T Durkin; G Thiriet; E Kempf; A Ebel
Journal:  J Neurosci Res       Date:  1985       Impact factor: 4.164

4.  Monoamines in the human neostriatum: topographic distribution in normals and in Parkinson's disease and their role in akinesia, rigidity, chorea, and tremor.

Authors:  S Fahn; L R Libsch; R W Cutler
Journal:  J Neurol Sci       Date:  1971-12       Impact factor: 3.181

5.  Effects of post-weaning environment and apparatus dimension on spontaneous alternation as a function of phenotype in "dwarf" mice.

Authors:  R Bouchon; B Will
Journal:  Physiol Behav       Date:  1983-02

6.  Biochemical aspects of release of norepinephrine and other amines from sympathetic nerve endings.

Authors:  I J Kopin
Journal:  Pharmacol Rev       Date:  1966-03       Impact factor: 25.468

7.  Serotonin--dopamine interactions in the nigrostriatal system.

Authors:  P C Waldmeier; A A Delini-Stula
Journal:  Eur J Pharmacol       Date:  1979-05-15       Impact factor: 4.432

8.  [Changes in cholinergic mechanisms and in learning in three strains of inbred mice after electric stimulation of the dorsal hippocampus].

Authors:  A Ebel; R Jaffard; C Destrade; G Ayad; P Mandel; B Cardo
Journal:  C R Acad Hebd Seances Acad Sci D       Date:  1976-09-20

9.  Postnatal action of growth and thyroid hormones on the retarded cerebral myelinogenesis of Snell dwarf mice (dw).

Authors:  T Noguchi; T Sugisaki; Y Tsukada
Journal:  J Neurochem       Date:  1982-01       Impact factor: 5.372

10.  Growth hormone and prolactin synthesis in normal and homozygous Snell and Ames dwarf mice.

Authors:  M B Slabaugh; M E Lieberman; J J Rutledge; J Gorski
Journal:  Endocrinology       Date:  1981-10       Impact factor: 4.736

View more
  1 in total

1.  Differential effects of delayed aging on phenotype and striatal pathology in a murine model of Huntington disease.

Authors:  Sara J Tallaksen-Greene; Marianna Sadagurski; Li Zeng; Roseanne Mauch; Matthew Perkins; Varuna C Banduseela; Andrew P Lieberman; Richard A Miller; Henry L Paulson; Roger L Albin
Journal:  J Neurosci       Date:  2014-11-19       Impact factor: 6.167

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.